In summary, our findings suggested that circEIF4G2 promotes renal tubular epithelial cell fibrosis via the miR‐218/SERBP1 pathway, presenting a novel insight for DN treatment. This evidence concerns the gene SERBP1 and liver dysplastic nodule.